SynthesisFrontiers in bioinformatics2025
Altered circRNAs: a novel potential mechanism for the functions of extracellular vesicles derived from platelet-rich plasma.
Synthesis in Frontiers in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the mechanism by which triphenyl phosphate promotes malignant phenotypes in bladder and kidney cancer through MMP9 based on bioinformatics analysis and experimental validation.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Platelet-rich plasma (PRP) has been widely applied in clinical practice for tissue repair and regeneration. Recent studies have reported that large amounts of extracellular vesicles (EVs) derived from PRP (PRP-EVs) are also involved in the functions of tissue repair and regeneration, except for the secreted growth factors. However, the relevant mechanisms of PRP-EVs remain unknown. In this study, we attempted to reveal the potential circular RNA (circRNA) mechanisms of PRP-EVs using high-throughput RNA sequencing (RNA-seq) technique and bioinformatics analysis. Six healthy donors were enrolled in this study, including three donors for the isolation of PRP-EVs and three donors for the isolation of EVs derived from blood plasma (plasma-EVs). As a result, we confirmed that PRP activation by thrombin could significantly promote the formation and secretion of EVs, particularly those with diameters ranging from 50 to 200 nm. Moreover, 144 circRNAs were altered in PRP-EVs with a fold change ≥ 2.0 and p-value ≤ 0.05. Among these, 89 circRNAs were upregulated, whereas 55 circRNAs were downregulated. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and circRNA-miRNA-mRNA interaction network analyses were performed to predict the potential roles of circRNAs in PRP-EVs. GO analysis indicated that these altered circRNAs might be related to the physiological processes of cell genesis and development. The pathways that were most strongly correlated with the biological functions of PRP-EVs were the transforming growth factor β (TGF-β) signaling pathway and HIF-1 signaling pathway. In addition, the expression levels of five selected circRNAs were verified through RT-qPCR. In conclusion, this is the first study to explain a novel potential mechanism of the biological functions of PRP-EVs in terms of the altered circRNAs. Taken together, our findings in this study may lay the groundwork for the clinical application of PRP-EVs and provide possible novel targets for further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.